Figure 3From: Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine Fold changes in investigational new biomarkers. Values are mean ± SEM fold changes post vs pre cholestyramine administration, N = 11, represented as fold change post-dosing over pre-dosing.Back to article page